1 / 33

 -cell apoptosis in T-cell mediated autoimmune diabetes

 -cell apoptosis in T-cell mediated autoimmune diabetes. Kurrer, M.O., S.V. Pakala, H.L. Hanson, and J. D. Katz. 1997.  -cell apoptosis in t-cell mediated autoimmune diabetes. Proceedings of the National Academy of Science 94: 213-218. Presented by Merlande M. Dieujuste.

bond
Download Presentation

 -cell apoptosis in T-cell mediated autoimmune diabetes

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. -cell apoptosis in T-cell mediated autoimmune diabetes Kurrer, M.O., S.V. Pakala, H.L. Hanson, and J. D. Katz. 1997. -cell apoptosis in t-cell mediated autoimmune diabetes. Proceedings of the National Academy of Science 94: 213-218. Presented by Merlande M. Dieujuste

  2. Insulin dependent diabetes mellitus (IDDM) • One of the 4 major types of diabetic disorders • ß-cells in the islets of the pancreas are destroyed by a T-cell mediated autoimmune attack • Presently no cure exists • If left untreated, other conditions can result

  3. Nonobese diabetic (NOD) mice are the models of choice • Pathogenesis of Type 1 Diabetes similar in nonobese diabetic (NOD) mice and humans • Female NOD mice develop insulitis by 4 weeks of age, diabetes at approximately 15 weeks of age • NOD mice helped recognize ß-cell destruction as the cause of IDDM

  4. Rational-Finding the mode of ß-cell death • In order to determine how ß-cells die, the following was initiated: • Complete studies in NOD strain mice • Analyze ß-cell destruction in situ, meaning within the tissues of the pancreas • Create a model in which the T-cells are specific to the destruction of the islet cells

  5. BDC2.5 T-cell receptor (TCR) transgenic mice crossed onto NOD.scid mice • Diabetogenic T-cell clone derived from an NOD mice • T-cell receptor genes rearranged in the CD4+ diabetogenic T-cell clone • Genes transferred into a transgenic mouse strain • BDC2.5 TCR transgenic mice created, then crossed onto NOD.scid mice • Mice were killed by cervical dislocation or CO2 ashyxiation

  6. Flow Cytometry, Accessing Diabetes • Three color flow cytometry used to analyze the thymus, the spleen and the lymph nodes for sole production of CD4+ T-cells • Diabetes was assessed by measuring venous blood through a glucose meter • Diabetes dated from first reading • Considered diabetic after two measurements > 250mg/dl

  7. Preparing pancreas sections • The pancreas were fixed and embedded in paraffin • Sections were deparaffinized and stained with hemotoxylin and eosin (H&E stain) • Terminal dideoxynucleotidetransferase (TdT)-mediated X-dUTP nick and end labeling (TUNEL) stain utilized to detect apoptosis • ß-cells were detected through immunohistochemistry staining for insulin

  8. Analyzing pancreas sections • An average of 100 islets per pancreas were analyzed • Sections were analyzed in five levels and insulitits was graded on scale range 0-3 • Level of insulitis determined for each islet, then divided by the total number of islets examined

  9. T-cell Transfer • Spleen and mesenteric lymph node cells from BDC2.5 TCR transgenic mice were cultured with mouse islet cells • Transferred to a second flask and supplemented with recombinant IL-2 • Cells analyzed by flow cytometry, then transferred intravenously into the mice • Spleens and mesenteric lymph nodes from diabetic BDC2.5/NOD.scid mice under went same process

  10. Experiment One-Selection of BDC2.5 mice in NOD. Scid mice • BDC2.5 TCR transgenic mice crossed onto NOD.scid mice • Elimination of all T and B lymphocytes except CD4+ T cells • Three-color flow cytometry performed on thymus and spleen cells from TCR/NOD.scid transgenic, TCR transgenic, and negative littermates

  11. Transgenic TCR expression selects CD4+ T cells in thymus

  12. Analyzing CD4, CD8, and V4 (TCR-) TCR expression

  13. Lack of CD8+ T cells in the spleen –top row

  14. Lack of CD8+ T cells in the spleen- middle row

  15. Lack of CD8+ T cells in the spleen- bottom row

  16. Result- Positive selection of the BDC2.5 TCR in NOD.scid mice • BDC2.5 TCR were able to bind and express only CD4+ T-cells • V4 was expressed only on CD4+ CD8- thymus cells • Normal T lymphocyte production favored the CD4+ subset • Normal levels of BDC2.5 TCR and CD4 co-receptor present

  17. Experiment 2- Progression to Insulitis and diabetes • Pancreas sections from 3-6 mice of each time group were analyzed • Presence of diabetes determined using a glucose meter • 80-100 islets cells scored for insulitis based on the following criteria: • 0= no insulitis • 1= peri- and mild insulitis • 2= moderate insulitis • 3= severe insulitis

  18. Scoring insulitis in BDC2.5/NOD.scid mice

  19. Rapid progression of insulitis • BDC2.5/NOD.scid mice had an advanced and acute development of insulitis • Accelerated insulitis commenced between 14-16 days • CD4+ T-cells, F4/80+ macrophage, RB6+ neutrophils, and natural killer cells present in the infiltrates

  20. Incidence of diabetes in BDC2.5/NOD.scid mice

  21. Rapid progression to diabetes • Several BDC2.5/NOD.scid mice became diabetic at 22 days old • All BDC2.5/NOD mice diabetic by 30 days old, and died from complications by approximately 33 days • Diabetes development was not accompanied by CD8+ T cells • BDC2.5 TCR+, CD4+ T cells accelerated progression of diabetes

  22. Experiment 3- Transferring insulitis and diabetes to NOD.scid mice • Observe whether or not insulitis and diabetes can be transferred efficiently • CD4+ T cells from severely diabetic BDC2.5/NOD.scid into 16 adult NOD.scid mice • Insulitis assessed and scored from H&E stained sections of pancreas • Incidence of diabetes assessed using a glucose meter

  23. Evidence of insulitis in NOD.scid recipient

  24. Incidence of Diabetes in NOD.scid recipient

  25. Result- Diabetes and insulitis accelerated in NOD.scid recipient • Severe and destructive insulitis by day 9-10 • All NOD.scid recipients had diabetes by day 11 (blood glucose less than or equal to 500)

  26. Experiment 4- Study and analyze -cell death in vivo • Rapid progression from insulitis to diabetes in BDC2.5/NOD.scid and NOD.scid mice • -cell death analyzed in pancreas from BDC2.5/NOD.scid mice (21-28 days) and NOD.scid mice (6-9 days) • Evidence of insulitis, necrosis, and apoptosis determined through immunohistochemistry

  27. -cell apoptosis in BDC2.5/NOD.scid mice

  28. Quantifying -cell apoptosis • Analyzed 31 NOD.scid recipients of direct transfer and in-vitro activated T cells • Randomized groups of recipients were killed at daily intervals • Analyzed pancreas for insulitis and apoptosis using TUNEL procedure, anti-insulin reagents and hemotoxylin

  29. Insulitic islets versus Total islets

  30. Result- Level of insulitis correlates with presence of apoptotic β-cells • Direct transfer and in-vitro-activated T cells gave similar results • Pancreas did not show signs of either insulitis or apoptosis after 3-4 days of transfer • One mouse had moderate insulitis 5 days after transfer • 12% of islets infiltrated by leukocytes showed one or more apoptotic β-cells • Severity of insulitis rose 7-10 days after transfer

  31. Apoptotic -cells are found in insulitic islets cells • Of 4500 islets examined, 1917 were insulitic • 233 islets had the occurrence of -cell apoptosis

  32. Overall Conclusion • BDC2.5 TCR transgenes crossed onto the NOD.scid mice is a simple and productive model • Sole presence of -cell specific CD4+ T-cells increases rate of diabetes onset • In-situ analysis allowed determination that -cells die by apoptosis • Apoptosis specific to islets cells with insulitis • Most likely occurs due through Fas/Fas-L or TNF-/TNF R pathways or by the IL-1/inducible nitric oxide synthase pathway

  33. ANY QUESTIONS??????

More Related